RNXT RenovoRx, Inc.

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed Apr 28, 2026 Processed 1mo ago SEC 9999999995-26-001342
IPO/offering going effective
Latest settled — T+20d
RNXT ▲ +10.83% at T+20d
NEUTRAL call ✓ call won +10.83% · α vs SPY +5.38% · entry $0.8400 → $0.9310
Next anchor: T+60d in 6w
Currently $0.8440 · +0.48% from $0.8400 entry
Entry anchored
Apr 28, 2026
via day open
T+1d
-1.07%
call -1.07% · α -1.06%
$0.8310
settled 6w ago
T+5d
+10.48%
call +10.48% · α +8.78%
$0.9280
settled 6w ago
T+20d
+10.83%
call +10.83% · α +5.38%
$0.9310
settled 17d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

RenovoRx's S-3 shelf registration (File No. 333-295108) became effective on April 27, 2026. This allows the company to offer and sell up to $50 million in various securities from time to time, creating potential dilution overhang for the $39M market cap stock.

Actionable Insight

The effective shelf creates a standing dilution risk. Monitor for prospectus supplements indicating a takedown — any announced offering would likely pressure the stock given the small market cap. The prior S-3 for selling stockholder resale adds further overhang.

Key Facts

  • S-3 shelf registration became effective on April 27, 2026
  • Allows offerings of common stock, preferred stock, warrants, debt securities, and other securities
  • Total gross proceeds capped at $50,000,000
  • Company market cap is approximately $39M, making the shelf size significant relative to current valuation
  • A prior S-3 filed April 16, 2026 (12 days ago) covers resale of up to 15.96 million shares by selling stockholders

Financial Impact

Up to $50 million in potential gross proceeds from future offerings, though no specific offering is announced

dilution

Risk Factors

  • Potential dilutive offering at any time without further notice
  • Shelf size ($50M) exceeds current market cap ($39M), signaling significant potential dilution
  • Prior S-3 for resale of 15.96M shares by selling stockholders adds additional overhang

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001342
Document: 9999999995-26-001342-index.html9999999995-26-001342
Document: 9999999995-26-001342.txt9999999995-26-001342
14 reports for RNXT
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +7.56%May 14, 2026
Filters
Rows
Reports for RNXT — sortable, filterable
Type Now
May 26, 2026
17d ago
Press Release
BULLISH ★ 5/10
$0.9160 $0.9210▲ +0.55%▼ −0.54%$0.8440 (−7.86%)
May 19, 2026
24d ago
Press Release
NEUTRAL ★ 3/10
$0.8060 $0.9052▲ +12.31%▲ +10.06%$0.8440 (+4.71%)
May 15, 2026
28d ago
10-K/A
NEUTRAL ★ 4/10
$0.7830 $0.9160▲ +16.99%▲ +15.37%$0.8440 (+7.79%)
May 14, 2026
29d ago
8-K
BULLISH ★ 5/10
$0.8200 $0.8820▲ +7.56%▲ +6.60%$0.8440 (+2.93%)
Apr 29, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$0.8310 $0.9280▲ +11.67%▲ +8.56%$0.8440 (+1.56%)
Apr 28, 2026
6w ago
EFFECT
NEUTRAL ★ 4/10
$0.8400 $0.9280▲ +10.48%▲ +8.78%$0.8440 (+0.48%)
Apr 16, 2026
8w ago
S-3
NEUTRAL ★ 4/10
$1.00 $0.8570▼ −14.30%▼ −14.85%$0.8440 (−15.60%)
Apr 14, 2026
8w ago
Press Release
BULLISH ★ 7/10
$1.03 $0.9490▼ −7.86%▼ −9.26%$0.8440 (−18.06%)
Mar 30, 2026
10w ago
8-K
MIXED ★ 6/10
$1.01 $0.9390▼ −7.03%▼ −10.97%$0.8440 (−16.44%)
Mar 30, 2026
10w ago
Press Release
MIXED ★ 6/10
$1.01 $0.9390▼ −7.03%▼ −10.97%$0.8440 (−16.44%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (49h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access